Literature DB >> 6712530

Pharmacokinetics of intra-arterial tumour therapy. An experimental study.

J von Scheel, G Golde.   

Abstract

Mathematically based pharmacokinetic models confirmed the general belief that intra-arterial (i.a.) cytostatic drug infusion can produce an increase in local tissue levels and a reduction in systemic drug availability. The increase in local drug concentration depends largely on the blood-flow rate of the infused artery and the rate of drug elimination from the rest of the body. In an experimental canine model the pharmacokinetics of i.a. infusion were studied using the femoral artery as the site of infusion and an Anger camera for continuous measurement of drug concentration in the target region. Several radioactively labelled drugs with different kinetics were infused over 80 min. The decay phase after the end of i.a. infusion was also monitored. The results indicate that even the femoral artery with its high blood flow is a suitable site for i.a. infusion, provided the plasma half-life of the drug is short enough. Consequently, arteries with lower blood flow (e.g., lingual artery) are even more suitable for i.a. infusion. The various diagrams obtained from this study provide a quick indication of whether or not a drug is suitable in a certain clinical situation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712530     DOI: 10.1007/bf00463556

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  21 in total

1.  Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report.

Authors:  C T KLOPP; T C ALFORD; J BATEMAN; G N BERRY; T WINSHIP
Journal:  Ann Surg       Date:  1950-10       Impact factor: 12.969

2.  Relations between histology, TNM-Category and results of treatment with methotrexate-bleomycin-combination in squamous cell carcinomas of the oral cavity.

Authors:  K Bitter
Journal:  J Maxillofac Surg       Date:  1973-06

3.  Intra-arterial bleomycin therapy in inoperable squamous cell carcinomas.

Authors:  M C Huntington; R W DuPriest; W S Fletcher
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

4.  [A new method of intraarterial chemotherapy of malignant head and neck tumors - first results (author's transl)].

Authors:  J von Scheel; E R Kastenbauer
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1982-05

5.  Intraarterial infusion chemotherapy for head and neck cancer using a totally implantable infusion pump.

Authors:  S R Baker; R H Wheeler; W D Ensminger; J E Niederhuber
Journal:  Head Neck Surg       Date:  1981 Nov-Dec

6.  [Animal experiments for intra-arterial chemotherapy with bleomycin (author's transl)].

Authors:  J Bier; E Loer; J Franke; H Platz
Journal:  Arch Otorhinolaryngol       Date:  1980

7.  Intra-arterial cisplatin treatment of adenoid cystic carcinoma.

Authors:  R B Sessions; D E Lehane; R J Smith; R N Bryan; J Y Suen
Journal:  Arch Otolaryngol       Date:  1982-04

8.  External carotid artery infusion with single-and multiple-drug regimens in the rat.

Authors:  P F Schouwenburg; L M Van Putten; G B Snow
Journal:  Cancer       Date:  1980-05-01       Impact factor: 6.860

9.  [Methodical aspects of intra-arterial chemotherapy of malignant head and neck tumors (author's transl)].

Authors:  J von Scheel
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1981-05

10.  Intra-arterial infusion with methotrexate in the rat.

Authors:  P J Sindram; G B Snow; L M van Putten
Journal:  Br J Cancer       Date:  1974-10       Impact factor: 7.640

View more
  3 in total

1.  Selective Intra-Arterial Lutetium-177-Labeled Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: Initial Results.

Authors:  Haluk B Sayman; Fatih Gulsen; Sait Sager; Elife Akgun; Nami Yeyin; Seckin Bilgic; Kubra N Toplutas; Feifei An; Fatih Beytur; Rahmi Oklu; Omer Aras
Journal:  J Vasc Interv Radiol       Date:  2021-10-27       Impact factor: 3.682

2.  Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs.

Authors:  W T N Culp; C Weisse; A C Berent; J A Reetz; E L Krick; D E Jackson; P H Kass; C A Clifford; K U Sorenmo
Journal:  J Vet Intern Med       Date:  2015-04-21       Impact factor: 3.333

Review 3.  Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.

Authors:  Erin A Gibson; Roger E Goldman; William T N Culp
Journal:  Vet Sci       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.